Table 2.

Summary of meta-analyses of specific cancer risk in diabetes.

Cancer type	Authors [reference]	Year of publication	No. of cohort/no. of case-control studies	Risk estimates (95% CI)
Liver	Wang et al. [47]	2012	25/0	SRR = 2.01 (1.61–2.51)
Pancreas	Ben et al. [64]	2011	35/0	RR = 1.94 (1.66–2.27)
Colon and rectum	Deng et al. [77]	2012	16/8	RR = 1.26 (1.20–1.31)
Esophagus	Huang et al. [86]	2012	11/6	SSR = 1.30 (1.12–1.50)
Kidney	Larsson and Wolk [88]	2011	9/0	RR = 1.42 (1.06–1.91)
Bladder	Larsson et al. [96]	2006	9/7	RR = 1.24 (1.08–1.42)
Breast	Liao et al. [103]	2011	7/5	RR = 1.25 (1.20–1.29)
Endometrium	Friberg et al. [104]	2007	3/13	RR = 2.1 (1.75–2.53)
Blood	Castillo et al. [107]	2012	13/13	NHL OR = 1.22 (1.07–1.39) Leukemia OR = 1.22 (1.03–1.44) Myeloma OR = 1.22 (0.98–1.53)